Editorial: Reverse Vaccinology

Richard Moxon¹, Pedro A Reche², Rino Rappuoli^{3

4}

Affiliations

¹ Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
² Department of Immunology & O2, Complutense University of Madrid, Madrid, Spain.
³ GSK, Siena, Italy.
⁴ Faculty of Medicine, Imperial College, London, United Kingdom.

Editorial

Richard Moxon et al. Front Immunol. 2019.

. 2019 Dec 3:10:2776.

doi: 10.3389/fimmu.2019.02776. eCollection 2019.

Richard Moxon¹, Pedro A Reche², Rino Rappuoli^{3

4}

¹ Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
² Department of Immunology & O2, Complutense University of Madrid, Madrid, Spain.
³ GSK, Siena, Italy.
⁴ Faculty of Medicine, Imperial College, London, United Kingdom.

No abstract available

Keywords: infectious diseases; microbiology; reverse vaccinology; vaccines; vaccinology.

Comment on

1. Sanchez-Trincado JL, Gomez-Perosanz M, Reche PA. Fundamentals and methods for T- and B-cell epitope prediction. J Immunol Res. (2017) 2017:2680160. 10.1155/2017/2680160 - DOI - PMC - PubMed
1. Lu DR, Tan YC, Kongpachith S, Cai X, Stein EA, Lindstrom TM, et al. Identifying functional anti-Staphylococcus aureus antibodies by sequencing antibody repertoires of patient plasmablasts. Clin Immunol. (2014) 152:77–89. 10.1016/j.clim.2014.02.010 - DOI - PMC - PubMed
1. Zimmermann N, Thormann V, Hu B, Köhler AB, Imai-Matsushima A, Locht C, et al. Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis. EMBO Mol Med. (2016) 8:1325–39. 10.15252/emmm.201606330 - DOI - PMC - PubMed
1. Williams AE, Edwards L, Humphreys IR, Snelgrove R, Rae A, Rappuoli R, et al. . Innate imprinting by the modified heat-labile toxin of Escherichia coli (LTK63) provides generic protection against lung infectious disease. J Immunol. (2004) 173:7435–43. 10.4049/jimmunol.173.12.7435 - DOI - PubMed